Liquid Biopsy Market Gaining Momentum in Cancer Diagnostics
The global liquid biopsy market is witnessing notable growth driven by advancements in non-invasive cancer diagnostics. Liquid biopsy enables early detection, monitoring, and personalized treatment planning through blood-based biomarkers. Increasing cancer prevalence, demand for precision medicine, and technological innovations are shaping the market landscape. As per insights by MarkNtel Advisors, the industry continues to evolve with expanding clinical applications and research developments.